Friday 16 October 2026
Export CDXS’s income statement to Excel — free account
Codexis, Inc.
CDXS Healthcare Biotechnology
Codexis, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $70.4 million, up 18.6% from fiscal 2024. In the quarter to June 2026, revenue fell 2.69%, EPS grew 18.8%, free cash flow grew 48.6% and total debt fell 14.1%, each against the same quarter a year earlier.
1.25
0.11
−8.09%
Follow CDXS
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
3 | 4 | 5 | 5 |
| (114.26%) | (74.88%) | (68.90%) | (69.36%) | ||
| (47.00%) | (29.63%) | (24.77%) | (23.79%) | ||
ROIC |
(195.29%) | (218.36%) | (100.87%) | (151.17%) | |
Return on Tangible Assets |
(89.16%) | (52.03%) | (41.34%) | (50.94%) | |
Average Days of Receivables |
52.43 | 52.86 | 35.46 | 34.33 | |
Free Cash Flow per Share |
(0.68) | (0.27) | (0.24) | (0.13) | |
Free Cash Flow |
(61.65) | (23.84) | (22.11) | (12.16) | |
Capital Expenditures |
(5.72) | (4.47) | (3.39) | (1.76) | |
| Other line items | |||||
Cash ROIC |
(44.85%) | (14.08%) | (14.81%) | (9.96%) | |
Accounts Receivable Turnover |
5.11 | 5.70 | 8.98 | 6.90 | |
Accounts Payable Turnover |
3.30 | 4.25 | 2.12 | 4.95 | |
Inventory Turnover |
5.42 | 5.16 | 4.59 | 5.69 | |
Average Days of Payables |
80.84 | 60.74 | 89.55 | 94.44 | |
Days of Inventory on Hand |
64.54 | 71.02 | 84.20 | 57.99 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
99.53% | 74.31% | 65.07% | 62.75% | |
Selling, General and Administrative Expense of Revenue |
92.45% | 66.88% | 56.98% | 55.50% | |
Share Based Compensation of Revenue |
18.80% | 13.67% | 11.11% | 9.94% | |
Interest Coverage |
(8.30) | (8.67) | (5.68) | (5.05) | |
Operating CF/Net income |
0.87 | 0.44 | 0.59 | 0.34 | |
Depreciation/Fixed assets |
0.49 | 0.54 | 0.59 | 0.64 | |
Capex/Depreciation |
(0.84) | (0.63) | (0.45) | (0.23) | |
Revenue per Share |
0.59 | 0.81 | 0.86 | 0.85 | |
Operating CF per Share |
(0.62) | (0.22) | (0.21) | (0.11) | |
Capex per Share |
(0.06) | (0.05) | (0.04) | (0.02) | |
Capex to Sales |
0.11 | 0.06 | 0.04 | 0.02 |
Columns are period end dates